Quarterly report pursuant to Section 13 or 15(d)

Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details)

v3.24.1.u1
Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Securities borrowed or purchased under agreements to resell    
Gross Assets/Liabilities $ 737,496 $ 703,641
Amounts Offset (421,403) (423,017)
Net Balance Sheet Amount 316,093 280,624
Financial Instruments (289,161) (257,541)
Net Assets/Liabilities 26,932 23,083
Securities loaned or sold under agreements to repurchase    
Gross Liabilities 751,061 706,904
Amounts Offset (421,403) (423,017)
Net Balance Sheet Amount 329,658 283,887
Financial Instruments (315,535) (272,285)
Net Liabilities 14,123 11,602
Other    
Gross Liabilities 12,144 10,066
Amounts Offset 0 0
Net Balance Sheet Amount 12,144 10,066
Financial Instruments (12,144) (10,066)
Net Liabilities 0 0
Total Securities Financing Agreements Liability    
Gross Liabilities 763,205 716,970
Amounts Offset (421,403) (423,017)
Net Balance Sheet Amount 341,802 293,953
Financial Instruments (327,679) (282,351)
Net Liabilities 14,123 11,602
Loans and leases repurchase activity $ 9,400 $ 8,700